US Stocks Movement | Soleno surges over 33%, acquired by Neurocrine for $2.9 billion

2026-04-07 02:55:14

Gelonghui April 6｜Soleno is up more than 33%, the biggest intraday gain since March 2025. In terms of the news, Neurocrine Biosciences said on Monday that it will acquire Soleno Therapeutics for $2.9 billion in cash.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.